音乐干预对轻度认知障碍的老年人认知功能的影响:系统性审查
Research in gerontological nursing
|June 19, 2023
概括
音乐干预显著改善了轻度认知障碍 (MCI) 的老年人认知功能. 需要进一步的研究来证实这些对认知健康的好处.
科学领域:
- 老年学是指老年学的学科.
- 神经科学是一个神经科学.
- 音乐治疗 音乐治疗
背景情况:
- 轻度认知障碍 (MCI) 影响老年人,对认知健康构成挑战.
- 老龄化人口的认知衰退需要有效的干预措施.
- 音乐干预提供了一个潜在的非药物治疗方法来支持认知功能.
研究的目的:
- 系统地审查音乐干预对被诊断为轻度认知障碍 (MCI) 的老年人认知功能的影响.
- 综合现有研究证据,研究音乐对该群体各种认知领域的影响.
主要方法:
- 在主要数据库 (CINAHL,PubMed,PsycINFO,Web of Science) 进行系统的文献搜索.
- 包括专注于音乐干预和MCI老年人的认知结果的研究.
- 用于分析干预后的认知结果的叙事合成.
主要成果:
- 十一项研究符合纳入标准.
- 音乐干预显示了全球认知功能,语言流性,执行功能和空间功能的显著改善.
- 研究设计的异质性和一些研究中的偏差风险被注意到.
结论:
- 音乐干预显示承诺作为一种有效的策略,以提高MCI的老年人的认知功能.
- 由于研究异质性和潜在的偏见,研究结果需要谨慎解释.
- 建议进一步进行高质量的研究,以探索各种音乐干预的特定领域影响.
相关概念视频
Cognitive Development During Adulthood
165
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
165
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
165
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
165
Alzheimer's Disease: Treatment
223
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
223


